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Dynamic Nuclear Polarization (DNP) by the so-called 'dissolution' procedure 1 is rapidly gaining momentum as a novel method to enhance weak nuclear magnetic resonance (NMR) signals from molecular tracers, so that one can visualize their biodistribution and metabolism in ViVo. 2 The major limitation of the technique arises from the short lifetimes of hyperpolarized spin states in liquids. In particular, longitudinal relaxation times T 1 of protons in solutions of biomolecules are too short to allow for transport and in ViVo injection of hyperpolarized compounds. Most applications of the technique have therefore focused on 13 C NMR of 13 C-enriched tracers containing nonprotonated carbons with T 1 ( 13 C) ≈ 20-40 s. Choline (CH 3 ) 3 N + CH 2 CH 2 OH plays a key role in several critical biological processes, in particular in the synthesis and metabolism of phospholipids in cell membranes, and in cholinergic neurotransmission. Although the choline molecule does not contain any slowly relaxing carbons, it possesses a quaternary nitrogen with T 1 ( 15 N) > 120 s, which lends itself to hyperpolarization. 3 The conversion of choline to phosphocholine catalyzed by choline kinase has recently been monitored by 15 N NMR in Vitro, 3 employing hyperpolarization of 15 N spins. In ViVo measurements using this method may, however, be hampered by insufficient 15 N peak separation of choline metabolites (∼ 0.2 ppm for phosphocholine vs choline, i.e., only 6 Hz in a field B 0 ) 7 T) and by poor sensitivity of 15 N NMR. A sensitivity improvement by at least an order of magnitude would be required, e.g., to monitor phosphocholine accumulation in tumor cell cultures. 4 The above limitations may be overcome by transferring the hyperpolarization from 15 N to protons, as in recent heteronuclear 2D DNP-NMR experiments. 5 A similar concept was recently used for 13 C enhanced by PASADENA. 6 In this work, we show that one can transfer the long-lived Figure 1A . The peak at 3.19 ppm, which stems from the nine magnetically equivalent methyl protons, is commonly used for in ViVo quantification of choline-containing compounds, 7 whereas the multiplets due to the NCH 2 (3.50 ppm) and CH 2 O protons (4.05 ppm) 8 exhibit an AA′XX′ pattern. 9 The Figure 2A shows the DNP-enhanced 15 N-detected spectrum of the same solution as used for the experiment in Figure 1B . The enhancement factor was 13 400 compared to a thermal-equilibrium spectrum obtained with 140 scans, 90°pulses, and a repetition time of 1000 s (not shown). Nearly the same enhancement factor was reported by Gabellieri et al. 3 at 9.4 T, using a commercial DNP polarizer working at 3.35 T and 1.4 K with trityl radicals as the polarizing agent. The thermal-equilibrium (Boltzmann) polarization can be estimated to be P( at T ) 298 K and B 0 ) 7 T. The enhanced polarization P( 15 N) was thus 3.3%, which is consistent with the polarization level measured in the 6 M solid sample prior to dissolution.
To explore the effect of partial deuteration on the relaxation of N-choline (O) and choline-d 9 (0), obtained using a series of 10°and 15°pulses, respectively. The curves represent three-parameter exponential fits to signal amplitudes that were corrected for magnetization losses due to the small-angle pulses (filled symbols).
